1. A 15‐year, single institution experience of anticoagulation management in paroxysmal nocturnal hemoglobinuria patients on terminal complement inhibition with history of thromboembolism. Issue 2 (29th November 2021) Authors: Gerber, Gloria F.; DeZern, Amy E.; Chaturvedi, Shruti; Brodsky, Robert A. Journal: American journal of hematology Issue: Volume 97:Issue 2(2022) Page Start: E59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Autoimmune disease in CMML-the chicken or the egg?. Issue 2 (June 2020) Authors: Ambinder, Alexander J.; Miller, John; DeZern, Amy E. Journal: Baillière's best practice and research in clinical haematology Issue: Volume 33:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome. Issue 2 (June 2021) Authors: Karantanos, Theodoros; DeZern, Amy E. Journal: Baillière's best practice and research in clinical haematology Issue: Volume 34:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Consensus minimum hemoglobin level above which patients with myelodysplastic syndromes can safely forgo transfusions. Issue 12 (14th October 2020) Authors: Tanasijevic, Anna M.; Revette, Anna; Klepin, Heidi D.; Zeidan, Amer; Townsley, Danielle; DiNardo, Courtney D.; Sebert, Marie; DeZern, Amy E.; Stone, Richard M.; Magnavita, Emily S.; Chen, Richard; Sekeres, Mikkael A.; Abel, Gregory A. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detection of paroxysmal nocturnal hemoglobinuria clones to exclude inherited bone marrow failure syndromes. (18th March 2014) Authors: DeZern, Amy E.; Symons, Heather J.; Resar, Linda S.; Borowitz, Michael J.; Armanios, Mary Y.; Brodsky, Robert A. Journal: European journal of haematology Issue: Volume 92:Number 6(2014:Jun.) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)*. Issue 6 (3rd June 2017) Authors: DeZern, Amy E.; Zeidan, Amer M.; Barnard, John; Hand, Wesley; Al Ali, Najla; Brown, Francis; Zimmerman, Cassie; Roboz, Gail J.; Garcia-Manero, Guillermo; Steensma, David P.; Komrokji, Rami S.; Sekeres, Mikkael A. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 6(2017) Page Start: 1325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation. Issue 2 (10th January 2022) Authors: Gibson, Christopher J.; Kim, Haesook T.; Zhao, Lin; Murdock, H. Moses; Hambley, Bryan; Ogata, Alana; Madero-Marroquin, Rafael; Wang, Shiyu; Green, Lisa; Fleharty, Mark; Dougan, Tyler; Cheng, Chi-An; Blumenstiel, Brendan; Cibulskis, Carrie; Tsuji, Junko; Duran, Madeleine; Gocke, Christopher D.; An... Journal: Journal of clinical oncology Issue: Volume 40:Issue 2(2022) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. Issue 14 (10th May 2021) Authors: Sallman, David A.; DeZern, Amy E.; Garcia-Manero, Guillermo; Steensma, David P.; Roboz, Gail J.; Sekeres, Mikkael A.; Cluzeau, Thomas; Sweet, Kendra L.; McLemore, Amy; McGraw, Kathy L.; Puskas, John; Zhang, Ling; Yao, Jiqiang; Mo, Qianxing; Nardelli, Lisa; Al Ali, Najla H.; Padron, Eric; Korbel, ... Journal: Journal of clinical oncology Issue: Volume 39:Issue 14(2021) Page Start: 1584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes. Issue 34 (1st December 2022) Authors: Mishra, Asmita; Tamari, Roni; DeZern, Amy E.; Byrne, Michael T.; Gooptu, Mahasweta; Chen, Yi-Bin; Deeg, H. Joachim; Sallman, David; Gallacher, Phillip; Wennborg, Anders; Hickman, Denice K.; Attar, Eyal C.; Fernandez, Hugo F. Journal: Journal of clinical oncology Issue: Volume 40:Issue 34(2022) Page Start: 3985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction. (August 2019) Authors: Hambley, Bryan C.; Norsworthy, Kelly J.; Jasem, Jagar; Zimmerman, Jacquelyn W.; Shenderov, Eugene; Webster, Jonathan A.; Showel, Margaret M.; Gondek, Lukasz P.; Dalton, William B.; Prince, Gabrielle; Gladstone, Douglas E.; Streiff, Michael B.; Pratz, Keith W.; Gojo, Ivana; Ghiaur, Gabriel; Levis,... Journal: Leukemia research Issue: Volume 83(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗